Authors:
de Gast, GC
Klumpen, HJ
Vyth-Dreese, FA
Kersten, MJ
Verra, NCV
Sein, J
Batchelor, D
Nooijen, WJ
Schornagel, JH
Citation: Gc. De Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1267-1272